April 25, 2017 2:57 AM ET


Company Overview of OctoPlus N.V.

Key Executives for OctoPlus N.V.

NameBoard RelationshipsTitleAge
Jan Hendrik Egberts M.D., Ph.D., MBA78 RelationshipsChief Executive Officer and Member of Executive Board58
Susan M. Swarte 4 RelationshipsChief Financial Officer and Member of Executive Board46

OctoPlus N.V. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.) 101 RelationshipsDr. Reddy's Laboratories Limited56
Daan Crommelin Ph.D. 10 RelationshipsAGLAIA BioMedical Ventures B.V.--
Douwe D. Breimer Ph.D. 20 RelationshipsLife Sciences Partners BV--
W. E. Hennink 7 RelationshipsOctoPlus N.V.--
Peter van Brummelen Ph.D., M.D. 15 RelationshipsEnceladus Pharmaceuticals BV73
View All Board Members

OctoPlus N.V. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Supervisory Board B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Gunupati Venkateswara Prasad101 Relationships3 Executives
Advisory Board Ph.D.Daan Crommelin10 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation$668.0K
Total Value of Options
Compensation as of Fiscal Year
OctoPlus N.V. CEO Compensation
Industry Average


Purdue Pharma Appoints Carrie Chomiak as Business Lead for OTC Product Franchise
April 21, 2017 5:17 PM ET
Phosphagenics Limited Announces Board Changes
April 20, 2017 11:42 PM ET
Provectus Biopharmaceuticals, Inc. Reestablishes Strategic Advisory Board
April 20, 2017 8:17 PM ET
VANC Pharmaceuticals Inc. Appoints Alan Arnstein to its Board of Directors
April 20, 2017 5:06 PM ET
Dipexium Pharmaceuticals, Inc. Announces Executive Changes
April 20, 2017 10:05 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OctoPlus N.V., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.